When the United States begins to question the way European countries set drug prices, it is not just another trade dispute. In fact, it is opening up one of the most fundamental debates in modern healthcare: how to ensure timely availability of modern medicines, how to share the costs of innovation among individual...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
When the United States begins to question the way European countries set drug prices, it is not just another trade dispute. In fact, it is opening up one of the most fundamental debates in modern healthcare: how to ensure timely availability of modern medicines, how to share the costs of innovation among individual...